{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:52:30Z","timestamp":1783446750293,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004900.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000}}],"reference-count":106,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004900.pub3","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T05:16:52Z","timestamp":1605849412000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Botulinum toxin type A therapy for blepharospasm"],"prefix":"10.1002","volume":"2020","author":[{"given":"Gon\u00e7alo S","family":"Duarte","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Therapeutics; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"},{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe B","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Therapeutics; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"},{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel E","family":"Marques","sequence":"additional","affiliation":[{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"},{"name":"Ophthalmology University Clinic; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mafalda","family":"Castel\u00e3o","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Therapeutics; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"},{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Therapeutics; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"},{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sampaio","sequence":"additional","affiliation":[{"name":"CHDI Foundation; Princeton NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austen P","family":"Moore","sequence":"additional","affiliation":[{"name":"The Walton Centre NHS Foundation Trust; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Costa","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Therapeutics; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"},{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"issue":"Suppl 2","key":"10.1002\/14651858.CD004900.pub3-BIB0001|cit1","first-page":"S206","article-title":"IncobotulinumtoxinA (NT-201) injections are safe and effective in adult subjects with blepharospasm across dosing intervals in a repeated dose-study","volume":"26","author":"Brodsky","year":"2011","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1016\/j.jns.2013.07.403","article-title":"Long-term treatment of blepharospasm and cervical dystonia: Incobotulinum toxin A is well tolerated when injected at flexible intervals based on patient needs","volume":"333","author":"Fernandez","year":"2013","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0003|cit3","first-page":"S29","article-title":"Efficacy and safety of NT 201 (botulinum neurotoxin type A free from complexing proteins) for the treatment of blepharospasm: results of a double-blind, placebo-controlled, randomized, multicenter trial","volume":"2","author":"Grafe","year":"2010","journal-title":"Physical Medicine and Rehabilitation"},{"issue":"8","key":"10.1002\/14651858.CD004900.pub3-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/mds23658","article-title":"Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm - a randomized trial","volume":"26","author":"Jankovic","year":"2011","journal-title":"Movement Disorders"},{"issue":"9","key":"10.1002\/14651858.CD004900.pub3-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"1345-53","DOI":"10.1007\/s00702-013-0998-9","article-title":"Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(\u00ae)) injections in blepharospasm","volume":"120","author":"Truong","year":"2013","journal-title":"Journal of Neural Transmission"},{"issue":"Suppl 15","key":"10.1002\/14651858.CD004900.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"P5.041","DOI":"10.1212\/WNL.90.15_supplement.P5.041","article-title":"Safety and efficacy of incobotulinum toxin A for the treatment of blepharospasm in botulinum toxin-naive subjects","volume":"90","author":"Mitsikostas","year":"2018","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0007|cit7","unstructured":"Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid clinicaltrials.gov\/show\/NCT01896895"},{"issue":"5","key":"10.1002\/14651858.CD004900.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.parkreldis.2007.11.003","article-title":"Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial","volume":"14","author":"Truong","year":"2008","journal-title":"Parkinsonism and Related Disorders"},{"issue":"3","key":"10.1002\/14651858.CD004900.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/jnnp.59.3.309","article-title":"Pretarsal application of botulinum toxin for treatment of blepharospasm","volume":"59","author":"Aramideh","year":"1995","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD004900.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/IOP.0b013e31819946c4","article-title":"High versus low concentration botulinum toxin A for benign essential blepharospasm: does dilution make a difference?","volume":"25","author":"Boyle","year":"2009","journal-title":"Ophthalmic Plastic and Reconstructive Surgery"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004900.pub3-BIB0011|cit11","first-page":"271","article-title":"Double-blind controlled study of botulinum toxin for blepharospasm","volume":"35","author":"Fahn","year":"1985","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0002-9394(14)76386-X","article-title":"The effect of omitting botulinum toxin from the lower eyelid in blepharospasm treatment","volume":"106","author":"Frueh","year":"1988","journal-title":"American Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD004900.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/mds.870110107","article-title":"Unilateral injection of botulinum toxin in blepharospasm: single fiber electromyography and blink reflex study","volume":"11","author":"Girlanda","year":"1996","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1002\/14651858.CD004900.pub3-BIB0014|cit14","first-page":"663","article-title":"Botulinum toxin type A (Botox) for treatment of blepharospasm: an open label, dose response study","volume":"99","author":"Iwashige","year":"1995","journal-title":"Nihon Ganka Gakkai Zasshi"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1212\/WNL.37.4.616","article-title":"Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study","volume":"37","author":"Jankovic","year":"1987","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0016|cit16","first-page":"583","article-title":"Blepharospasm and oromandibular-laryngeal cervical dystonia: a controlled trial of botulinum A toxin therapy","volume":"50","author":"Jankovic","year":"1988","journal-title":"Advances in Neurology"},{"issue":"5","key":"10.1002\/14651858.CD004900.pub3-BIB0017|cit17","first-page":"686","article-title":"Apraxia of lid opening","volume":"10","author":"Jankovic","year":"1995","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1002\/14651858.CD004900.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/jnnp.60.6.704","article-title":"Pretarsal injection of botulinum toxin for blepharospasm and apraxia of eyelid opening","volume":"60","author":"Jankovic","year":"1996","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD004900.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1212\/WNL.45.3.506","article-title":"Comparison of therapeutic efficacies of type A and F botulinum toxins for blepharospasm: a double-blind, controlled study","volume":"45","author":"Mezaki","year":"1995","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD004900.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/1531-8257(199911)14:6<1017::AID-MDS1018>3.0.CO;2-3","article-title":"Combined use of type A and F botulinum toxins for blepharospasm: a double-blind controlled trial","volume":"14","author":"Mezaki","year":"1999","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1002\/14651858.CD004900.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00941758","article-title":"Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm","volume":"235","author":"Nussgens","year":"1997","journal-title":"Graefes Archives of Clinical and Experimental Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD004900.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3346\/jkms.1993.8.5.334","article-title":"Botulinum A toxin treatment of hemifacial spasm and blepharospasm","volume":"8","author":"Park","year":"1993","journal-title":"Journal of Korean Medical Science"},{"issue":"5","key":"10.1002\/14651858.CD004900.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0161-6420(97)30220-6","article-title":"Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections","volume":"104","author":"Price","year":"1997","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD004900.pub3-BIB0024|cit24","first-page":"387","article-title":"DYSBOT: a single blind, randomized clinical trial to compare two different formulations of botulinum toxin type A","volume":"10","author":"Sampaio","year":"1995","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1002\/14651858.CD004900.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/mds.870120627","article-title":"DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A - Dysport and Botox - assuming a ratio of 4:1","volume":"12","author":"Sampaio","year":"1997","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1002\/sim.2423","article-title":"Meta-analysis of heterogeneously reported trials assessing change from baseline","volume":"24","author":"Abrams","year":"2005","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-1331.2010.03042.x","article-title":"EFNS guidelines on diagnosis and treatment of primary dystonias","volume":"18","author":"Albanese","year":"2011","journal-title":"European Journal of Neurology"},{"issue":"7","key":"10.1002\/14651858.CD004900.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2288-2-3","article-title":"Meta-analysis, Simpson's paradox, and the number needed to treat","volume":"2","author":"Altman","year":"2002","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"3689-96","DOI":"10.1523\/JNEUROSCI.0375-08.2008","article-title":"Long-distance retrograde effects of botulinum neurotoxin","volume":"28","author":"Antonucci","year":"2008","journal-title":"Journal of Neuroscience"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/brain\/117.1.27","article-title":"Electromyographic features of levator palpebrae superioris and orbicularis oculi muscles in blepharospasm","volume":"117","author":"Aramideh","year":"1994","journal-title":"Brain"},{"issue":"4","key":"10.1002\/14651858.CD004900.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/brain\/108.3.593","article-title":"Pathophysiology of blepharospasm and oromandibular dystonia","volume":"108","author":"Berardelli","year":"1985","journal-title":"Brain"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0034|cit34","first-page":"495-504","article-title":"On the question of permeability of the blood-brain barrier to botulinum toxin","volume":"48","author":"Boroff","year":"1975","journal-title":"International Archives of Allergy and Applied Immunology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1477-7525-4-69","article-title":"How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure","volume":"4","author":"Bro\u017cek","year":"2006","journal-title":"Health and Quality of Life Outcomes"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0036|cit36","first-page":"129","volume-title":"Handbook of Dystonia","author":"Cardoso","year":"1995"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0037|cit37","doi-asserted-by":"crossref","DOI":"10.1002\/9781119942283","volume-title":"Multiple Imputation and its Application","author":"Carpenter","year":"2013"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2015.12.007","article-title":"Improving GRADE evidence tables part 1: a randomized trial shows improved understanding of content in summary of findings tables with a new format","volume":"74","author":"Carrasco-Labra","year":"2016","journal-title":"Journal of clinical epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD004900.pub3-BIB0039|cit39","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003633.pub3","article-title":"Botulinum toxin type A therapy for cervical dystonia","author":"Castel\u00e3o","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0040|cit40","volume-title":"Statistical Power Analysis in the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"1","key":"10.1002\/14651858.CD004900.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jrsm.1090","article-title":"Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool","volume":"5","author":"Corbett","year":"2014","journal-title":"Research Synthesis Methods"},{"issue":"1","key":"10.1002\/14651858.CD004900.pub3-BIB0042|cit42","article-title":"Botulinum toxin type A therapy for hemifacial spasm","author":"Costa","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0043|cit43","first-page":"3200-5","article-title":"Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals","volume":"96","author":"Paiva","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0044|cit44","unstructured":"Deeks JJ Higgins JPT Altman DG Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available at www.training.cochrane.org\/handbook"},{"issue":"10","key":"10.1002\/14651858.CD004900.pub3-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004314.pub3","article-title":"Botulinum toxin type A versus botulinum toxin type B for cervical dystonia","author":"Duarte","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.parkreldis.2018.06.017","article-title":"Adverse events with botulinum toxin treatment in cervical dystonia: how much should we blame placebo?","volume":"56","author":"Duarte","year":"2018","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"10.1002\/14651858.CD004900.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0022-510X(71)90129-8","article-title":"An electron microscopic study of the changes induced by botulinum toxin in the motor end-plates of slow and fast skeletal muscle fibres of the mouse","volume":"14","author":"Duchen","year":"1971","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/eye.1988.79","article-title":"The significance of ophthalmological symptoms in idiopathic blepharospasm","volume":"2","author":"Elston","year":"1988","journal-title":"Eye"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"400-4","DOI":"10.3109\/00016489309135834","article-title":"Botulinum A toxin effects on rat jaw muscle spindles","volume":"113","author":"Filippi","year":"1993","journal-title":"Acta Oto-laryngologica"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(92)90054-Q","article-title":"Variance imputation for overviews of clinical trials with continuous response","volume":"45","author":"Follmann","year":"1992","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0051|cit51","first-page":"325","article-title":"Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?","volume":"4","author":"Frevert","journal-title":"Biologics: Targets & Therapy"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD004900.pub3-BIB0052|cit52","first-page":"OP591","article-title":"A profile of patients with intractable blepharospasm","volume":"81","author":"Frueh","year":"1976","journal-title":"Transactions of the American Academy of Ophthalmology and Otolaryngology"},{"issue":"1","key":"10.1002\/14651858.CD004900.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0054|cit54","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.51.6.767","article-title":"Blepharospasm: a review of 264 patients","volume":"51","author":"Grandas","year":"1988","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD004900.pub3-BIB0056|cit56","first-page":"307","article-title":"Blink reflex recovery cycle in patients with blepharospasm unilaterally treated with botulinum toxin","volume":"21","author":"Grandas","year":"1998","journal-title":"Clinical Neuropharmacology"},{"issue":"12","key":"10.1002\/14651858.CD004900.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence-imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0058|cit58","volume-title":"Statistical Methods for Meta-Analysis","author":"Hedges","year":"1985"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0059|cit59","first-page":"453","article-title":"Essential blepharospasm","volume":"54","author":"Henderson","year":"1956","journal-title":"Transactions of the American Academy of Ophthalmology Society"},{"issue":"7414","key":"10.1002\/14651858.CD004900.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0061|cit61","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available at www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0062|cit62","unstructured":"Higgins JPT Deeks JJ Altman DG Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available at www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0063|cit63","unstructured":"Higgins JPT Deeks JJ Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available at www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1167-79","DOI":"10.1016\/0306-4522(81)90081-6","article-title":"Nerve growth in botulinum toxin poisoned muscles","volume":"6","author":"Holland","year":"1981","journal-title":"Neuroscience"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ana.410110108","article-title":"Treatment of hyperkinetic movement disorders with tetrabenazine: a double blind crossover study","volume":"11","author":"Jankovic","year":"1982","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1001\/jama.1982.03330230060037","article-title":"Blinking and blepharospasm","volume":"248","author":"Jankovic","year":"1982","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ana.410130406","article-title":"Blepharospasm and orofacial-cervical dystonia: clinical and pharmacology findings in 100 patients","volume":"13","author":"Jankovic","year":"1983","journal-title":"Annals of Neurology"},{"issue":"7","key":"10.1002\/14651858.CD004900.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jnnp.2003.034702","article-title":"Botulinum toxin in clinical practice","volume":"75","author":"Jankovic","year":"2004","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004900.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0960-8966(96)00041-7","article-title":"Nerve terminal sprouting inbotulinum type-A treated mouse levator auris longus muscle","volume":"6","author":"Juzans","year":"1996","journal-title":"Neuromuscular Disorders: NMD"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1745-6215-15-49","article-title":"Developing core outcomes sets: methods for identifying and including patient-reported outcomes (PROs)","volume":"15","author":"Macefield","year":"2014","journal-title":"Trials"},{"issue":"5","key":"10.1002\/14651858.CD004900.pub3-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004315.pub3","article-title":"Botulinum toxin type B for cervical dystonia","author":"Marques","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/jnnp.39.12.1204","article-title":"Blepharospasm-oromandimular dystonia syndrome","volume":"390","author":"Marsden","year":"1976","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0074|cit74","first-page":"39-59","article-title":"Botulinum toxin A, brain and pain","volume":"119-120","author":"Matak","journal-title":"Progress in Neurobiology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tox.2015.07.003","article-title":"Botulinum neurotoxin type A: actions beyond SNAP-25?","volume":"335","author":"Matak","year":"2015","journal-title":"Toxicology"},{"issue":"3","key":"10.1002\/14651858.CD004900.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/mds.870030302","article-title":"Epidemiology of focal and generalized dystonia in Rochester, Minnesota","volume":"3","author":"Nutt","year":"1988","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"23:54-60","DOI":"10.1016\/j.clinph.2011.05.032","article-title":"Neurophysiological changes after intramuscular injection of botulinum toxin","volume":"123","author":"Palomar","year":"2012","journal-title":"Clinical Neurophysiology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0078|cit78","first-page":"259-68","article-title":"Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses","volume":"354","author":"Pellizzari","year":"1999","journal-title":"Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences"},{"issue":"6","key":"10.1002\/14651858.CD004900.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jama.295.6.676","article-title":"Comparison of two methods to detect publication bias in meta-analysis","volume":"295","author":"Peters","year":"2006","journal-title":"Journal of the American Medical Association"},{"issue":"10","key":"10.1002\/14651858.CD004900.pub3-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S1474-4422(18)30310-7","article-title":"Strong nocebo effect in amyotrophic lateral sclerosis trials might mask conclusions","volume":"17","author":"Rato","year":"2018","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.parkreldis.2019.04.015","article-title":"Nocebo response in Parkinson's disease: a systematic review and meta-analysis","volume":"65","author":"Rato","year":"2019","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0082|cit82","unstructured":"Nordic Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"488-96","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8","article-title":"Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection","volume":"19","author":"Rosales","year":"1996","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"71-80","DOI":"10.1111\/j.1468-1331.2010.03056.x","article-title":"On muscle spindles, dystonia and botulinum toxin","volume":"17","author":"Rosales","year":"2010","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"585-98","DOI":"10.1002\/sim.4780100410","article-title":"Multiple imputation in health-care databases: an overview and some applications","volume":"10","author":"Rubin","year":"1991","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0086|cit86","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and \u2018Summary of findings' tables. In: Higgins JPT, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available at www.training.cochrane.org\/handbook"},{"issue":"23","key":"10.1002\/14651858.CD004900.pub3-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1212\/WNL.0000000000004004","article-title":"Placebo and nocebo responses in restless legs syndrome: a systematic review and meta-analysis","volume":"88","author":"Silva","year":"2017","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","article-title":"Identification of the major steps in botulinum toxin action","volume":"44","author":"Simpson","year":"2004","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"10","author":"Simpson","year":"2016","journal-title":"Neurology"},{"issue":"7197","key":"10.1002\/14651858.CD004900.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1136\/bmj.318.7197.1548","article-title":"Numbers needed to treat derived from meta-analysis - sometimes informative, usually misleading","volume":"318","author":"Smeeth","year":"1999","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0091|cit91","unstructured":"Stata StataCorp. 2017"},{"issue":"14","key":"10.1002\/14651858.CD004900.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/mds.25244","article-title":"The prevalence of primary dystonia: a systematic review and meta-analysis","volume":"27","author":"Steeves","year":"2012","journal-title":"Movement Disorders"},{"issue":"10","key":"10.1002\/14651858.CD004900.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0094|cit94","unstructured":"Sterne JAC Egger M Moher D Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available at www.training.cochrane.org\/handbook 2011"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMra055549","article-title":"Dystonia","volume":"355","author":"Tarsy","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0096|cit96","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA) ctu.dk\/tsa\/files\/tsa \u0307manual.pdf 2011"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/archneur.1979.00500460069010","article-title":"Meige's disease: a clinical form of a facial convulsion, bilateral and medial","volume":"36","author":"Tolosa","year":"1979","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/archneur.1981.00510030041005","article-title":"Clinical features of Meige's disease (idiopathic orofacial dystonia): a report of 17 cases","volume":"36","author":"Tolosa","year":"1981","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0099|cit99","first-page":"73","article-title":"Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects","author":"Tolosa","year":"1988","journal-title":"Advances in Neurology"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0100|cit100","unstructured":"Copenhagen Trial Unit Trial Sequential Analysis. Version 0.9 Beta Copenhagen Trial Unit 2011"},{"issue":"1","key":"10.1002\/14651858.CD004900.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1034\/j.1600-0404.2001.00109.x","article-title":"Quality of life in patients with blepharospasm","volume":"103","author":"Tucha","year":"2001","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD004900.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1745-6215-8-38","article-title":"OMERACT: an international initiative to improve outcome measurement in rheumatology","volume":"8","author":"Tugwell","year":"2007","journal-title":"Trials"},{"issue":"2","key":"10.1002\/14651858.CD004900.pub3-BIB0103|cit103","first-page":"31","article-title":"Comparison and overview of currently available neurotoxins","volume":"7","author":"Walker","year":"2014","journal-title":"Journal of Clinical and Aesthetic Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD004900.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jclinepi.2005.08.017","article-title":"A systematic review identifies a lack of standardization in methods for handling missing variance data","volume":"59","author":"Wiebe","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD004900.pub3-BIB0105|cit105","first-page":"2519-26","article-title":"Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value","volume":"259","author":"Zoons","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD004900.pub3-BIB0106|cit106","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004900.pub2","article-title":"Botulinum toxin type A therapy for blepharospasm","author":"Costa","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T19:36:42Z","timestamp":1723923402000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004900.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Movement Disorders Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":106,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004900.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]}}}